Evidence map›Paper›PMID 33800082›Full record

ArticleInternational journal of molecular sciences2021

Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against

Paweł Krzyżek, Paweł Migdał, Emil Paluch, Magdalena Karwańska, Alina Wieliczko, Grażyna Gościniak

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Beyond Antibiotics: Alternative Strategies TargetingExpert reviews in molecular medicine · 2026
    Review
  2. Reversal of tetracycline resistance by clove and peony extracts in a multi-drug resistant Escherichia coli.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Novel anti-virulence strategy againstFrontiers in microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Towards EffectiveInternational journal of molecular sciences · 2025
    Review
  8. New Quipazine Derivatives Active Against Drug-Resistant OncogenicInternational journal of molecular sciences · 2025
    Article
  9. HalogenatedACS medicinal chemistry letters · 2025
    Article
  10. Review
  11. Nanomaterials: A Prospective Strategy for Biofilm-FormingInternational journal of nanomedicine · 2025
    Review
  12. Opportunities forMicroorganisms · 2024
    Review
  13. Optimization ofInternational journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Anti-Pharmaceutics · 2024
    Article
  18. Article
  19. Frontiers in pharmacology · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paweł KrzyżekDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-3117-8894
Paweł MigdałDepartment of Environment, Hygiene and Animal Welfare, Wroclaw University of Environmental and Life Sciences, 51-630 Wroclaw, Poland.ORCID 0000-0002-2615-9760
Emil PaluchDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-3549-6136
Magdalena KarwańskaDepartment of Epizootiology and Veterinary Administration with Clinic of Infectious Diseases, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, 50-366 Wroclaw, Poland.
Alina WieliczkoDepartment of Epizootiology and Veterinary Administration with Clinic of Infectious Diseases, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, 50-366 Wroclaw, Poland.ORCID 0000-0001-7018-6507
Grażyna GościniakDepartment of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-6597-9609
Wroclaw Medical University · PLWrocław University of Environmental and Life Sciences · PL

Funding

Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu STM.A130.20.002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBiofilmsDrug SynergismFlavonoidsGene Expression Regulation, BacterialHelicobacter pyloriMicrobial Sensitivity TestsAnti-Bacterial AgentsFlavonoidsmyricetinbiofilmcheckerboard assaycoccoid formsHelicobacter pylorimorphological transformationmyricetinsynergism

Identifiers

PMID33800082
PMCPMC7962197
OpenAlexW3134093686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.